Huntington Disease
📧 Sign up to get email alerts when something new happens for Huntington Disease.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2009-12-09FDA Approved: HALOPERIDOL — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA approved a supplemental application for HALOPERIDOL LACTATE from Hikma Pharmaceuticals USA Inc., authorizing modifications under the AND…
-
FDA approval · 2009-12-01FDA Approved: XENAZINE — Supplemental Application (Lundbeck Pharmaceuticals LLC)
The FDA approved a supplemental application for Xenazine (tetrabenazine) submitted by Lundbeck Pharmaceuticals LLC.
-
CLINICAL_TRIALS trial_result · 2009-11-18Clinical Trial Update: A Phase I Study To Estimate The Effect Of Ketoconazole And Omeprazole On The Pharmacokinetics Of Dimebon In Healthy Subjects Who Are Normal Or Poor CYP2D6 Metabolizers [Phase 1]
Phase I pharmacokinetic study to estimate how ketoconazole and omeprazole affect the exposure of dimebon in healthy volunteers, including bo…
-
FDA approval · 2009-09-14FDA Approved: HALOPERIDOL LACTATE — Original Application (Mylan Institutional LLC)
FDA approved the original application for HALOPERIDOL LACTATE from Mylan Institutional LLC, authorizing a generic injectable form of haloper…
-
CLINICAL_TRIALS trial_result · 2009-06-12Clinical Trial Update: Dimebon (PF-01913539)-Digoxin Drug-Drug Interaction Study In Healthy Subjects [Phase 1]
A Phase 1 clinical trial update evaluating the drug-drug interaction between Dimebon (PF-01913539) and digoxin in healthy subjects, complete…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2009-03-09Clinical Trial Update: A Phase 1 Study To Evaluate The Effect Of Dimebon On The Pharmacokinetics Of Dextromethorphan [Phase 1]
A Phase 1 trial evaluating whether Dimebon affects the pharmacokinetics of Dextromethorphan; the study in Huntington disease and Alzheimer d…
-
CLINICAL_TRIALS research · 2009-02-05Clinical Trial Update: Ursodiol in Huntington's Disease [Phase 1]
Phase 1 clinical trial evaluating ursodiol for Huntington's disease; status not specified.
-
CLINICAL_TRIALS trial_result · 2009-01-16Clinical Trial Update: Family Health After Predictive Huntington Disease (HD) Testing
A completed clinical trial from the National Institute of Nursing Research assessing family health outcomes after predictive testing for Hun…
-
CLINICAL_TRIALS research · 2009-01-05Clinical Trial Update: Far Infrared Irradiation for Managing, Control and Treatment of Huntington's Disease (HD) [Phase 1]
A Phase 1 clinical trial is evaluating far infrared irradiation for Huntington's disease, with no results reported and the trial status list…
-
FDA approval · 2008-08-15FDA Approved: XENAZINE — Original Application (Lundbeck Pharmaceuticals LLC)
The FDA approved Xenazine (tetrabenazine) under Lundbeck's original NDA.
-
CLINICAL_TRIALS trial_result · 2008-03-04Clinical Trial Update: Effects of Lithium and Divalproex'on Brain-Derived Neurotrophic Factor in Huntington's Disease [Phase 2]
A Phase 2 trial evaluating the effects of lithium and divalproex on brain-derived neurotrophic factor in Huntington's disease has completed.
-
CLINICAL_TRIALS trial_result · 2008-03-04Clinical Trial Update: Treatment of Huntington's Chorea With Amantadine [Phase 2]
Phase 2 clinical trial evaluating amantadine for Huntington's chorea has been completed.
-
CLINICAL_TRIALS trial_result · 2008-01-04Clinical Trial Update: Safety Study of the Novel Drug Dimebon to Treat Patients With Huntington's Disease [Phase 1, Phase 2]
Clinical trial update reports completion of a Phase 1/Phase 2 safety study of Dimebon (latrepirdine) for Huntington's disease.
-
CLINICAL_TRIALS trial_result · 2007-12-27Clinical Trial Update: TREND-HD - A Trial of Ethyl-EPA (Miraxion™) in Treating Mild to Moderate Huntington's Disease [Phase 3]
This entry notes that the Phase 3 TREND-HD trial of Ethyl-EPA (Miraxion) for Huntington's disease has completed.
-
CLINICAL_TRIALS trial_result · 2006-08-18Clinical Trial Update: Creatine Therapy for Huntington's Disease [Phase 1, Phase 2]
The document reports completion of Phase 1 and Phase 2 evaluations of creatine therapy in Huntington's disease.